Braveheart Bio, Inc. (BRVE)

Braveheart Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025
Period Ending	Nov 10, 2026	Dec 31, 2025
Market Capitalization	1,602	-
Market Cap Growth	-	-
Enterprise Value	1,479	-

Financial Efficiency

Fiscal Year	Current	FY 2025
Period Ending	Nov 10, 2026	Dec 31, 2025
Net Debt / Equity Ratio	-1.04	-1.06
Quick Ratio	13.56	17.01
Current Ratio	13.63	17.03
Return on Capital Employed (ROCE)	-30.00%	-5.40%

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Sep 8, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error